Clinical Trials Sponsored by Vertanical GmbH

Total 3284 results

CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Morquio Disease (BioMorquio) (BioMorquio)

Morquio Syndrome A | Morquio Syndrome | Morquio B Disease | Accumulation of Mucopolysaccharides

Germany, India, Sri Lanka, Egypt
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Pompe Disease (BioPompe) (BioPompe)

Lung Disease | Cerebral Aneurysm | Macroglossia | Cardiac Diseases | Obstructive Sleep Apnoea | Muscular Weakness | Hepato-splenomegaly

Germany, India, Sri Lanka
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for Gilbert Disease (BioGilbert) (BioGilbert)

Hyperbilirubinemia | Meulengracht Syndrome | Unconjugated Benign Bilirubinemia

India, Sri Lanka, Egypt
Stryker Trauma GmbH

Completed

Aequalis Pyrocarbon IDE; Replacing the Humeral Head in Hemi-Arthroplasty (PYC)

Osteoarthritis | Avascular Necrosis | Traumatic Arthritis

United States
BSN Medical GmbH

Terminated

Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing

Wounds and Injuries | Skin Diseases

Germany
CytoSorbents Europe GmbH

Withdrawn

CytoSorb® in Patients With Acute on Chronic Liver Failure (HepOnFire)

Alcoholic Hepatitis | Acute on Chronic Liver Failure

Germany
Valneva Austria GmbH

Withdrawn

COVID-19 Paediatric VLA2001-321 Study

SARS-CoV-2 Infection
Immunovant Sciences GmbH

Terminated

ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )

Graves' Ophthalmopathy (GO)

United States, Germany, Spain, Canada, Italy
CENTOGENE GmbH Rostock

Enrolling by invitation

Biomarker for Friedreich's Ataxia (BioFridA) (BioFridA)

Hereditary Diseases | FXN Gene | FRDA

Lebanon
Immunovant Sciences GmbH

Terminated

To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA). (ASCEND-WAIHA)

Warm Autoimmune Hemolytic Anemia

United States, Korea, Republic of, Israel, United Kingdom, Spain, Thailand
Merz Pharmaceuticals GmbH

Completed

Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines. (ULTRA II)

Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)

Germany
Stryker Trauma GmbH

Terminated

A Post-Market Clinical Evaluation of the ReUnion TSA System

Shoulder Arthroplasty

United States
Stryker Trauma GmbH

Terminated

Collecting Orthopedic Safety and Performance Data Using Surgeons Clinical Outcomes Registry (SCOR) (SCOR)

Orthopedics

United States
Myovant Sciences GmbH

Completed

LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Uterine Fibroid | Heavy Menstrual Bleeding

United States, Belgium, Czechia, South Africa, Chile, Brazil, Hungary, Poland
Hologic Deutschland GmbH

Completed

Comparison of the Hologic Genius Digital Diagnostics System With the ThinPrep Imaging System

Cervical Cancer Screening

Germany
Pari Pharma GmbH

Completed

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi

Rhinosinusitis | Chronic Polyposis

Germany
GWT-TUD GmbH

Completed

Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS) (E-TRAB)

Advanced Soft-tissue Sarcoma | Metastatic Soft-tissue Sarcoma

Germany, Austria, Switzerland
Cardior Pharmaceuticals GmbH

Completed

Clinical Study to Assess Safety, PK and PD Parameters of CDR132L

Heart Failure

United Kingdom
AGO Research GmbH

Terminated

Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer

Recurrent Ovarian Carcinoma

Germany
Immunovant Sciences GmbH

Completed

Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)

Graves' Ophthalmopathy

Canada
Heidelberg ImmunoTherapeutics GmbH

Completed

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection (MATCH-2)

Herpes Genitalis

Germany
Evotec International GmbH

Completed

Blood and Urine Sample Collection From Healthy Volunteers

Healthy

Germany
Biofrontera Bioscience GmbH

Completed

Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)

Actinic Keratoses

United States
GWT-TUD GmbH

Terminated

Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib (PazoQoL)

Soft Tissue Sarcoma Adult

Germany
Myovant Sciences GmbH

Completed

Study of Relugolix Alone and Relugolix Combined With Hormonal Add-Back Therapy in Healthy Premenopausal Female Participants

Healthy

United States
Myovant Sciences GmbH

Completed

SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

Endometriosis Related Pain

United States, Spain, Hungary, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Poland, Portugal, South Africa, Ukraine
Mundipharma-EDO GmbH

Terminated

Tinostamustine Conditioning and Autologous Stem Cell (TITANIUM1)

Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Progression

Switzerland, United States, Norway
Stryker Trauma GmbH

Completed

Acellular Porcine Dermal Matrix Wound Dressing in the Management of Diabetic Foot Ulcers

Diabetic Foot Ulcers

United States
CENTOGENE GmbH Rostock

Completed

The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease (SWITCH)

Fabry Disease | Anderson-Fabry Disease | Fabry´s Disease

Argentina, Belgium, Croatia, Czechia, Denmark, France, Germany, United Kingdom
CENTOGENE GmbH Rostock

Completed

Induced Pluripotent Stem Cells for Niemann Pick Disease (IPSNPABC)

Niemann-Pick Diseases

Pakistan
CENTOGENE GmbH Rostock

Completed

Establishment of Human Cellular Disease Models for Wilson Disease (IPSWILSON)

Wilson Disease

Pakistan
CENTOGENE GmbH Rostock

Completed

Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis

Multiple Sclerosis
Croma-Pharma GmbH

Completed

Princess® RICH for the Correction of Fine Lines (RICH)

Lateral Canthal Lines | Perioral Rhytids

Austria
Cankado GmbH
Amgen

Completed

Health Economy Register (GeRA)

Breast Neoplasms

Germany
MVZ Leopoldina GmbH

Completed

Effects of a Paleolithic Lifestyle Intervention in Breast Cancer Patients Undergoing Radiotherapy

Breast Cancer | Body Weight Changes

Germany
Valneva Austria GmbH

Completed

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Japanese Encephalitis

Australia, United States, Germany
Herrmann Apparatebau GmbH

Terminated

Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia (HAB)

Hypertonia

Germany
Croma-Pharma GmbH

Completed

Study of Etafill in Patients With Cataract Surgery Via the Anterior Chamber

Cataract Surgery

Austria
BSN Medical GmbH

Completed

Feasibility Study Focusing on Fit of Made-to-measure Compression Garments in Healthy Subjects

Product Use Issue

Germany
Merz Pharmaceuticals GmbH

Completed

Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face (POMET)

Correction of Facial Wrinkles/Folds | Facial Volume Enhancement

Germany
Croma-Pharma GmbH

Completed

Study of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber

Cataract Surgery

Austria
Segeberger Kliniken GmbH

Completed

A Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: The CHOICE Trial (CHOICE)

Aortic Stenosis

Germany
Hepa Wash GmbH

Terminated

Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units (HEPATICUS-2)

Critical Illness | Liver Dysfunction

Germany
Heidelberg Engineering GmbH

Terminated

Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module

Normal Eyes | Retinal Vascular

United States
Croma-Pharma GmbH

Completed

Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars (FLASH2)

Facial Lipoatrophy | Morphological Asymmetry of the Face | Debilitating Scars

Austria
Croma-Pharma GmbH

Completed

Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds (FINO)

Correction of Nasolabial Folds

Austria
AbbVie
Raffeiner GmbH

Completed

Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice (Adherence)

Rheumatoid Arthritis | Plaque Psoriasis | Ulcerative Colitis | Psoriatic Arthritis | Ankylosing Spondylitis | Crohn´s Disease
CSD Labs GmbH

Completed

Automated Phonocardiography Analysis in Adults

Aortic Stenosis | Mitral Insufficiency | Tricuspid Regurgitation | Aortic Insufficiency | Mitral Insufficiency and Aortic Stenosis | Insufficiency, Pulmonary | Insufficiency, Tricuspid

Austria
Berlin Cures GmbH

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy Subjects

Healthy Volunteers

Germany
CSD Labs GmbH

Completed

Automatic Differentiation of Innocent and Pathologic Murmurs in Pediatrics

Systolic Murmurs | Heart Murmurs | Mitral Valve Prolapse

Canada

Clinical Trials Sponsored by Vertanical GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations